Literature DB >> 10717808

Worldwide differences in the incidence of insulin autoimmune syndrome (Hirata disease) with respect to the evolution of HLA-DR4 alleles.

Y Uchigata1, Y Hirata, Y Omori, Y Iwamoto, K Tokunaga.   

Abstract

The relationship between the geographic distribution of susceptibility genes to insulin autoimmune syndrome (IAS) and the incidence of insulin autoimmune syndrome was investigated in order to examine the distribution of the genetic background to susceptibility to certain diseases. The HLA-DR4 allele, DRB1*0406, is associated with increased susceptibility to IAS among Japanese, while the DRB1*0403 and DRB1*0407 alleles are not (the odds ratio of which are 1.6 and 1.1, respectively). The worldwide geographic distribution of the three DR*04 alleles showed that the distribution of DRB1*0403 encompassed that of DRB1*0406 and DRB1*0407. Taken together with the findings that Glu at position 74 in the DRB1 molecule is shared by the three DRB1*04 alleles, there are only a few differences between the DRB1 molecule-nucleotide sequences of DRB1*0403, DRB1*0406 and DRB1*0407, and that all the three DRB1*04 alleles are carried by the same class II haplotype, DQA1*0301/DQB1*0302, it may be considered that DRB1*0403 is the ancestral allele of DRB1*0406 and DRB1*0407. Therefore, populations with a higher prevalence of DRB1*0406 have a higher risk of developing IAS. The extremely low prevalence of IAS among Caucasians can be explained by the low prevalence of DRB1*0406 in this population. This is a good example of the association between the predisposition to risk of development of certain diseases and the evolution of susceptibility genes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10717808     DOI: 10.1016/s0198-8859(99)00144-5

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  13 in total

1.  Insulin autoimmune syndrome induced by methimazole in a patient with Graves' disease.

Authors:  W-C Zhao; J Jin; J-Z Zhang
Journal:  J Endocrinol Invest       Date:  2013-06       Impact factor: 4.256

2.  Insulin autoimmune syndrome: a case associated with HLA-DRB1 polymorphism.

Authors:  Q Zhang; S-G Chen; C-J Sheng; X-Y Cheng; H Li; H Sheng; P Yang; C-H Qian; W-J Li; S Qu
Journal:  J Endocrinol Invest       Date:  2011 Jul-Aug       Impact factor: 4.256

Review 3.  Clinical and Laboratory Aspects of Insulin Autoantibody-Mediated Glycaemic Dysregulation and Hyperinsulinaemic Hypoglycaemia: Insulin Autoimmune Syndrome and Exogenous Insulin Antibody Syndrome.

Authors:  Tony Huynh
Journal:  Clin Biochem Rev       Date:  2020-12

4.  Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes.

Authors:  George S Eisenbarth
Journal:  Diabetes       Date:  2010-04       Impact factor: 9.461

Review 5.  Insulin autoimmune syndrome: from diagnosis to clinical management.

Authors:  Simona Censi; Caterina Mian; Corrado Betterle
Journal:  Ann Transl Med       Date:  2018-09

6.  Insulin autoimmune syndrome induced by α-lipoic acid in a Caucasian woman: case report.

Authors:  Enrico Bresciani; Anna Bussi; Elena Bazzigaluppi; Gianpaolo Balestrieri
Journal:  Diabetes Care       Date:  2011-09       Impact factor: 19.112

7.  Unusual Manifestations of Essential Monoclonal Gammopathy. II. Simulation of the Insulin Autoimmune Syndrome.

Authors:  Marshall A Lichtman; Sophia R Balderman
Journal:  Rambam Maimonides Med J       Date:  2015-07-30

8.  Two cases of methimazole-induced insulin autoimmune syndrome in graves' disease.

Authors:  Eun Roh; Ye An Kim; Eu Jeong Ku; Jae Hyun Bae; Hye Mi Kim; Young Min Cho; Young Joo Park; Kyong Soo Park; Seong Yeon Kim; Soo Heon Kwak
Journal:  Endocrinol Metab (Seoul)       Date:  2013-03-25

9.  Insulin Autoimmune Syndrome: a rare cause of postprandial hypoglycemia.

Authors:  Pooja Sahni; Nitin Trivedi; Abdulkadir Omer
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2016-10-11

10.  Hypoglycemic coma due to insulin autoimmune syndrome induced by methimazole: A rare case report.

Authors:  Yiyi Zhang; Tieyun Zhao
Journal:  Exp Ther Med       Date:  2014-09-15       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.